WO2002074353A1 - Sintering of bioactive glass with localised electromagnetic and/or acoustic energy - Google Patents
Sintering of bioactive glass with localised electromagnetic and/or acoustic energy Download PDFInfo
- Publication number
- WO2002074353A1 WO2002074353A1 PCT/FI2002/000191 FI0200191W WO02074353A1 WO 2002074353 A1 WO2002074353 A1 WO 2002074353A1 FI 0200191 W FI0200191 W FI 0200191W WO 02074353 A1 WO02074353 A1 WO 02074353A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bioactive glass
- irradiation
- acoustic energy
- sintering
- devices
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/10—Ceramics or glasses
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
- C03B19/00—Other methods of shaping glass
- C03B19/06—Other methods of shaping glass by sintering, e.g. by cold isostatic pressing of powders and subsequent sintering, by hot pressing of powders, by sintering slurries or dispersions not undergoing a liquid phase reaction
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
- C03B23/00—Re-forming shaped glass
- C03B23/20—Uniting glass pieces by fusing without substantial reshaping
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
- C03B32/00—Thermal after-treatment of glass products not provided for in groups C03B19/00, C03B25/00 - C03B31/00 or C03B37/00, e.g. crystallisation, eliminating gas inclusions or other impurities; Hot-pressing vitrified, non-porous, shaped glass products
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C17/00—Surface treatment of glass, not in the form of fibres or filaments, by coating
- C03C17/02—Surface treatment of glass, not in the form of fibres or filaments, by coating with glass
- C03C17/04—Surface treatment of glass, not in the form of fibres or filaments, by coating with glass by fritting glass powder
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C24/00—Coating starting from inorganic powder
- C23C24/08—Coating starting from inorganic powder by application of heat or pressure and heat
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C24/00—Coating starting from inorganic powder
- C23C24/08—Coating starting from inorganic powder by application of heat or pressure and heat
- C23C24/10—Coating starting from inorganic powder by application of heat or pressure and heat with intermediate formation of a liquid phase in the layer
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23D—ENAMELLING OF, OR APPLYING A VITREOUS LAYER TO, METALS
- C23D15/00—Joining enamelled articles to other enamelled articles by processes involving an enamelling step
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23D—ENAMELLING OF, OR APPLYING A VITREOUS LAYER TO, METALS
- C23D5/00—Coating with enamels or vitreous layers
- C23D5/04—Coating with enamels or vitreous layers by dry methods
Definitions
- the object of the invention is to provide a method for sintering bioactive glass or bioactive glass composite, a method for coating a device with bioactive glass or bioactive glass composite and a method for attaching at least two devices.
- An aim of the invention is to provide a method for manufacturing different devices of bioactive glass and bioactive glass composites.
- the devices may be for example implants that will resorb and be replaced by the patients own tissue (for example bone).
- the cements and glues used i.e. in dental medicine to attach an implant made of bioactive glass may not be used since they do not resorb. Furthermore, as cement disintegrates in the high temperatures needed to sterilise an implant, it thus loses its mechanical properties.
- Another aim of the invention is to provide for a manufacturing method that does not affect the biological activity of the device.
- SLS selective laser sintering
- the invention relates to a method for sintering bioactive glass or bioactive glass composite, in which method the sintering is performed with a localised electromagnetic and/or acoustic energy.
- the invention also relates to a method for coating a device with bioactive glass or bioactive glass composite. Said method is characterised in that at least one layer of bioactive glass or bioactive glass composite is deposited on the surface of the device and that each said layer is sintered with localised electromagnetic and/or acoustic energy prior to the deposition of another layer of bioactive glass or bioactive glass composite.
- the invention further relates to a method for attaching at least two devices, in which method the joint between said at least two devices is formed by sintering bioactive glass or bioactive glass composite present in the location of the joint with localised electromagnetic and/or acoustic energy.
- the invention relates to a method for sintering bioactive glass or bioactive glass composite, said method being characterised in that the sintering is performed with localised electromagnetic and/or acoustic energy.
- bioactive material it is meant a material that has been designed to induce specific biological activity.
- the electromagnetic and/or acoustic energy may be selected from energies that can be localised, such as different laser irradiations, infra-red irradiation, ultraviolet irradiation, .X-ray irradiation, microwave irradiation, ultrasound waves, gamma-irradiation, radioactivity, electron beam irradiation, acoustic waves, pressure waves and particle beam irradiation. It is obvious that the choice of the electromagnetic and/or acoustic energy is determined by the bioactive glass system used.
- the irradiations and/or waves are preferably used as impulses, whose frequency, intensity and advancement speed may be varied according to the result to be obtained.
- the advantage of using localised electromagnetic and/or acoustic energy is that sintering can be stimulated locally. Sintering can also be performed in a short period of time/surface area and in some cases it is possible to use lower vacuums than with the prior art techniques. This is advantageous for example in the case that a titanium-based device needs to be coated with bioactive glass or attached to another device. Titanium oxidizes very quickly in high temperatures and therefore the sintering time needs to be minimised.
- Another advantage of the invention is that by using filters or scanning of the irradiation and/or waves, a defined pattern can be made on the device or coating to be sintered. Yet another advantage of the invention is that the heat expansion coefficients of the used materials are not critical.
- the advantage of sintering materials with electromagnetic and/or acoustic energy or energies is to avoid raising the temperature and therefore avoid destroying organic or other temperature-sensitive components.
- the dissolution rate of the material in tissue is also fairly easily controllable.
- the bioactive glass composite according to this invention may comprise different materials such as polymers, metals or ceramics.
- biopolymers Either polymers based on renewable raw materials, e.g. cellulose, or synthetic polymers that are biodegradables, e.g. polylactides are meant by "biopolymer”.
- biodegradable in this context means that it is degradable upon prolonged implantation when inserted in the mammal body.
- biomaterial it is meant a non- viable material used in a medical device, intended to interact with biological systems.
- the additives or reinforcements used in the composites may be in various forms such as fibres, woven or nonwoven mats, particles or hollow particles. They may also be porous or dense materials, and it is obvious that they are preferably biocompatibles. By biocompatibility it is meant the ability of a material to perform with an appropriate host response in a specific application.
- the invention also relates to a method for coating a device with bioactive glass or bioactive glass composite, characterised in that at least one layer of bioactive glass or bioactive glass composite is deposited on the surface of the device and that each said layer is sintered with localised electromagnetic and/or acoustic energy prior to the eventual deposition of another layer of bioactive glass or bioactive glass composite.
- the surface to be coated may optionally be roughened in order to increase the surface of contact between the device and the coating. Same electromagnetic and/or acoustic energies may be used as above.
- the glass melts, thus forming micro-spheres solidly attached to the underlying surface of the device.
- the coating is formed of small micro-spheres of bioactive glass closely situated to each other and the result is a very thin layer of bioactive glass.
- a thick coating is preferably obtained by repeating the process a sufficient number of times.
- the thickness of the layer of bioactive glass or bioactive glass composite deposited on the surface of the device at one time is from 1 ⁇ m to 4000 ⁇ m, preferably from 10 ⁇ m to 500 ⁇ m, more preferably from 20 ⁇ m to 100 ⁇ m.
- the average particle size of the bioactive glass deposited on the surface of the device is from 10 ⁇ m to 2000 ⁇ m, preferably from 20 ⁇ m to 400 ⁇ m, more preferably from 30 ⁇ m to 300 ⁇ m.
- the particles may be in any desired form, that is for example spherical, cubic or fibrous form or prepared by crushing. Tooth-implants, hip-implants, knee-implants, mini plates, external fixation pins, stents (e.g., for use in repair of blood vessels), or any other metallic, polymeric, ceramic or organic implants can be coated with a bioactive glass layer. The coating dissolves in the tissue while a good adhesion between the tissue and the implant is formed, that is, the coating resorbs and is replaced by the patient's own tissue.
- the invention further relates to a method for attaching at least two devices, which method is characterised in that the joint between said at least two devices is formed by sintering bioactive glass or bioactive glass composite present in the location of the joint with localised electromagnetic and/or acoustic energy.
- Said devices may consist of any known material such as metals, polymers or ceramics.
- at least one of the devices has been coated or at least one of the devices is manufactured with bioactive glass or bioactive glass composite. The different embodiments of this method are discussed further below.
- inventive method may also be used to simply attach materials to each other, such as two different materials in the form of particles, wherein the resulting material is a composition of these two materials in the form of particles and of the bioactive glass forming the matrix.
- Said different materials may also be different kinds of bioactive glasses, and it is thus possible to form a device having different biological activities on different parts of the device.
- the invention can also be used for modifying the biological activity of bioactive glass or bioactive glass composite, wherein at least a portion of the surface of bioactive glass or bioactive glass composite is irradiated with a localised electromagnetic and/or acoustic energy.
- the devices of the invention may be in various forms, e.g., in the form of a particle, a disc, a film, a membrane, a tube, a hollow particle, a coating, a sphere, a semi sphere, or a monolith, and they may have various applications.
- Figure 1 illustrates coating of a device according to a first embodiment of the invention.
- Figure 2 illustrates coating of a device according to a second embodiment of the invention.
- Figure 3 illustrates attachment of two devices according to a third embodiment of the invention.
- Figure 4 illustrates attachment of two devices according to a fourth embodiment of the invention.
- Figure 5 illustrates attachment of two devices according to a fifth embodiment of the invention.
- Figure 6 illustrates attachment of two devices according to a sixth embodiment of the invention.
- Figure 7 illustrates attachment of two devices according to a seventh embodiment of the invention.
- Figure 8 illustrates modification of the biological activity of bioactive glass.
- Figure 9 shows a scanning. electron microscopy (SEM) image of the attachment of two devices according to the invention.
- Figure 10 shows a SEM back scattering image of bioactive glass sintered according to the invention.
- a layer 6 of essentially spherical bioactive glass particles 1 is deposited on the surface of a device 2. This layer is then scanned with C ⁇ 2-laser beam 3 in the direction indicated by the arrow 4 and under the effect of the laser beam, a sintered coating 5 is formed on the surface of the device 2, according to this first embodiment of the invention.
- the device 2 coated according to the embodiment shown in Figure 1 is further coated with a second layer of bioactive glass.
- a second layer 7 of bioactive glass particles 1 is deposited on the first layer of coating 5 and the second layer 7 is then scanned with C ⁇ 2-laser beam 3 in the direction indicated by the arrow 4.
- C ⁇ 2-laser beam 3 is scanned with C ⁇ 2-laser beam 3 in the direction indicated by the arrow 4.
- Figure 3 shows attachment of two devices to each other according to the third embodiment of the invention.
- the first device to be attached is the device 2 coated according to the second embodiment of the invention as shown in Figure 2.
- the second device 9 to be attached is manufactured from bioactive glass.
- a C ⁇ 2-laser beam 3 is first directed to the junction 10a of the two devices, where a solid joint is formed under the effect of the laser beam. Then the C ⁇ 2-laser beam 3 is directed to the junction 10b to form a solid joint (not shown). The devices 2 and 9 are thereby attached together.
- the first device 11 comprises a slot 12 in which the second device 13 is to be attached.
- the space between is filled with bioactive glass 14 and sintered with infrared irradiation 15.
- Figure 5 illustrates attachment of two devices according to a fifth embodiment of the invention.
- the first device 11 comprises a slot 12 in which the second device 16 is to be attached.
- the surface 18 of the slot 12 has been coated with bioactive glass in such a manner that the bioactive glass is only partially sintered.
- the sintering is finished once the second device 16 is in its final position and in this embodiment, the sintering is performed with ultraviolet irradiation 17.
- the first device 11 comprises a slot 12 in which the second device 19 is to be attached.
- the second device 19 consists of bioactive glass particles 20 and of reinforcing fibres 21.
- the reinforcing fibres 21 have all been positioned parallel to each other and perpendicular to the plane of the Figure.
- the surface of the device 19 consists essentially of the bioactive glass.
- the device 19 is placed in the slot 12 and the joint is made with X-ray irradiation 22.
- the first device 11 comprises a slot 12 in which the second device 23 is to be attached.
- Said second device 23 has been coated with bioactive glass as shown in Figure 1 and once the device 23 is placed in the slot 12, the remaining gap is filled with crushed particles 24 of bioactive glass.
- the joint is formed under the action of microwave irradiation 25.
- Figure 8 shows modification of the biological activity of a bioactive glass.
- a desired portion of the surface of a device 26 that has been previously sintered is treated with ultra-sound irradiation 27.
- the portions A and B of the surface are treated by scanning the ultra-sound irradiation 27 in the direction 28 on portion B and correspondingly on portion A of the surface.
- the portions C and D of the surface of the same device 26 are treated with infra-red irradiation 29 in the direction 30 on portion C and correspondingly on portion D of the surface. In this way, a different biological activity is obtained in portions A and B of the surface than in the portions C and D of the surface.
- Figure 9 shows a scanning electron microscopy (SEM) image of the attachment of two devices according to the invention.
- SEM scanning electron microscopy
- Figure 10 shows a SEM back scattering image of bioactive glass sintered according to the invention.
- the white dots reveal the formation of calcium phosphate due to the reaction of the bioactive glass with body fluid, thus showing its bioactivity.
- This calcium phosphate is similar to bone mineral.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/472,092 US20040086661A1 (en) | 2001-03-16 | 2002-03-12 | Sintering of bioactive glass with localised electromagnetic and/or acoustic energy |
JP2002573060A JP2004522546A (en) | 2001-03-16 | 2002-03-12 | Sintering of bioactive glass with localized electromagnetic and / or acoustic energy |
EP02706790A EP1368070A1 (en) | 2001-03-16 | 2002-03-12 | Sintering of bioactive glass with localised electromagnetic and/or acoustic energy |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27611201P | 2001-03-16 | 2001-03-16 | |
US60/276,112 | 2001-03-16 | ||
FI20010524A FI110481B (en) | 2001-03-16 | 2001-03-16 | Sintering of bioactive glass and their composites |
FI20010524 | 2001-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002074353A1 true WO2002074353A1 (en) | 2002-09-26 |
Family
ID=26161146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FI2002/000191 WO2002074353A1 (en) | 2001-03-16 | 2002-03-12 | Sintering of bioactive glass with localised electromagnetic and/or acoustic energy |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1368070A1 (en) |
JP (1) | JP2004522546A (en) |
WO (1) | WO2002074353A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526797A (en) * | 2012-02-08 | 2012-07-04 | 同济大学 | Preparation method of high-strength biological glass bone bracket with regular-hole distribution |
WO2019138249A1 (en) * | 2018-01-15 | 2019-07-18 | Ortheia Limited | Method of processing glass |
CN113842493A (en) * | 2021-09-13 | 2021-12-28 | 深圳先进技术研究院 | Preparation method of temperature-sensitive hydrogel and temperature-sensitive hydrogel |
US11382754B2 (en) | 2015-11-04 | 2022-07-12 | Traceray Oy | Bone implant |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005049886A1 (en) * | 2005-10-17 | 2007-04-19 | Sirona Dental Systems Gmbh | Tooth replacement part manufacturing method involves energy beam sintering powder material at the edge area to a greater density than in inner region by varying process parameters during sintering |
US20180127297A1 (en) * | 2016-11-10 | 2018-05-10 | Goodrich Corporation | Powder bed additive manufacturing of low expansion glass |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950294A (en) * | 1985-03-06 | 1990-08-21 | Olympus Optical Co., Ltd. | Composite structure useful as artificial bones |
US5242706A (en) * | 1991-07-31 | 1993-09-07 | The United States Of America As Represented By The Secretary Of The Navy | Laser-deposited biocompatible films and methods and apparatuses for producing same |
US5490962A (en) * | 1993-10-18 | 1996-02-13 | Massachusetts Institute Of Technology | Preparation of medical devices by solid free-form fabrication methods |
US6213168B1 (en) * | 1997-03-31 | 2001-04-10 | Therics, Inc. | Apparatus and method for dispensing of powders |
-
2002
- 2002-03-12 EP EP02706790A patent/EP1368070A1/en not_active Withdrawn
- 2002-03-12 JP JP2002573060A patent/JP2004522546A/en active Pending
- 2002-03-12 WO PCT/FI2002/000191 patent/WO2002074353A1/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950294A (en) * | 1985-03-06 | 1990-08-21 | Olympus Optical Co., Ltd. | Composite structure useful as artificial bones |
US5242706A (en) * | 1991-07-31 | 1993-09-07 | The United States Of America As Represented By The Secretary Of The Navy | Laser-deposited biocompatible films and methods and apparatuses for producing same |
US5490962A (en) * | 1993-10-18 | 1996-02-13 | Massachusetts Institute Of Technology | Preparation of medical devices by solid free-form fabrication methods |
US6213168B1 (en) * | 1997-03-31 | 2001-04-10 | Therics, Inc. | Apparatus and method for dispensing of powders |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526797A (en) * | 2012-02-08 | 2012-07-04 | 同济大学 | Preparation method of high-strength biological glass bone bracket with regular-hole distribution |
US11382754B2 (en) | 2015-11-04 | 2022-07-12 | Traceray Oy | Bone implant |
WO2019138249A1 (en) * | 2018-01-15 | 2019-07-18 | Ortheia Limited | Method of processing glass |
CN113842493A (en) * | 2021-09-13 | 2021-12-28 | 深圳先进技术研究院 | Preparation method of temperature-sensitive hydrogel and temperature-sensitive hydrogel |
Also Published As
Publication number | Publication date |
---|---|
JP2004522546A (en) | 2004-07-29 |
EP1368070A1 (en) | 2003-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rogowska-Tylman et al. | In vivo and in vitro study of a novel nanohydroxyapatite sonocoated scaffolds for enhanced bone regeneration | |
EP1357863B1 (en) | Compositions and methods for biomedical applications | |
KR100903761B1 (en) | Implant material and process for producing the same | |
Bartolo et al. | Biomedical production of implants by additive electro-chemical and physical processes | |
Wu et al. | Biomimetic porous scaffolds for bone tissue engineering | |
US20040121451A1 (en) | Treatment of sols, gels and mixtures thereof | |
CN101128226A (en) | Bioabsorbable composite material fiber | |
Cruz | Fabrication of HA/PLLA composite scaffolds for bone tissue engineering using additive manufacturing technologies | |
US20040086661A1 (en) | Sintering of bioactive glass with localised electromagnetic and/or acoustic energy | |
WO2002074353A1 (en) | Sintering of bioactive glass with localised electromagnetic and/or acoustic energy | |
JP2005531339A (en) | Tissue-engineered orthopedic scaffold | |
JP2008054908A (en) | Bone prosthetic material | |
Cristina | Materials processing and physical characterisation of a hybrid composite structure for bone replacement applications | |
JP4280968B2 (en) | Implant complex | |
Basu et al. | Fundamentals of scaffolds fabrication using low temperature additive manufacturing | |
US20220168104A1 (en) | Implant made of carrier material interspersed with biologically active donor material, and method for producing such an implant | |
Świeczko-Żurek | Porous materials used as inserted bone implants | |
JP6294852B2 (en) | Biological implant | |
Prodanov et al. | Initial cellular response to laser surface engineered biomaterials | |
Kamboj et al. | Bioactive Ceramic Scaffolds for Bone Tissue Engineering by Powder Bed Selective Laser Processing: A Review. Materials 2021, 14, 5338 | |
Almayyahi et al. | Additive Manufacturing of Bioscaffolds for Bone Regeneration | |
TWI252112B (en) | Implant material and process for producing the same | |
CN100355467C (en) | Compound system implanter unit for local tissue engineering | |
WO2002074354A1 (en) | Treatment of sols, gels, mixtures or composites of sols and gels, and/or sol-gel derived materials | |
WO2022220766A1 (en) | Hybrid, artificial bone tissue implant absorbing mechanical vibrations, whose architectural structure imitates trabecular bone, allowing the saturation of bone marrow, blood, and nutrients, supporting autological regeneration, which can be used with titanium structures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002706790 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002573060 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10472092 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2002706790 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002706790 Country of ref document: EP |